Our Latest News
Find our latest news below and follow us on our social media platforms.
RxCelerate & Babraham Research Campus host panel on “Prioritising mental health in the workplace”
Cambridge, UK 15th October 2024, 9AM GMTWorld Mental Health Day was on the 10th of October, and it is a day for mental health education, awareness and advocacy against social stigma. The aim of this year’s theme, “Mental Health in the Workplace”, was to highlight the...
PlaqueTec and RxCelerate collaborate on early phase drug discovery for coronary artery disease
Cambridge, UK Wednesday 18th September 2024, 9AM GMT Project evaluated small molecules against novel target in coronary artery disease discovered by PlaqueTec Bespoke cell-based assay developed by RxCelerate to test small molecules predicted to bind candidate target...
RxCelerate’s new company values, co-created by our people
Cambridge, UK, July 2024We are pleased to share our new company values – to support us as we continue building and developing as a people-first organisation. These values were shaped through a collaborative, company-wide initiative, where every employee was invited...
New Drosophila screening lab further expands RxCelerate’s drug discovery and development capabilities
Cambridge, UK Wednesday 24th April 2024, 9AM GMTRxCelerate is excited to launch our new fly screening service, further expanding the bespoke and flexible drug discovery and development services we offer. Cambridge, UK, 24 April 2024: The new lab offers cutting-edge...
RxCelerate acquires Methuselah Health and launches ProQuant™ world-beating proteomics service
Cambridge, UK and Cambridge, MA Tuesday 22nd November 2022, 1pm GMT RxCelerate, a leading international out-sourced drug discovery and development platform, today announced the acquisition of drug discovery company Methuselah Health UK Ltd for an undisclosed sum....
RxCelerate launch RxNfinity™: a next-generation machine learning-enabled small molecule discovery platform
Cambridge, UK and Cambridge, MA – Tuesday 19th July 2022, 1pm GMT RxCelerate, a leading international out-sourced drug discovery and development platform, today revealed details of a new small molecule discovery platform, RxNfinity™, that leverages machine learning,...